Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Infection enhancing culture medium and method for improving cell lentivirus infection rate

A medium and infection rate technology, applied in the direction of cell culture active agent, virus, culture process, etc., can solve the problems of gene editing efficiency constraints, low knockout positive rate, poor cell state, etc., to increase the infection rate of cell lentivirus , Improve the culture and infection rate, reduce the effect of operation difficulty and cost

Pending Publication Date: 2022-05-31
广州源井生物科技有限公司
View PDF15 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] MDA-MB-231 is widely used in research on triple-negative breast cancer. Gene editing through ZFN, TALEN, and CRISPR / Cas9 technologies to establish gene knockout, knockin, and point mutation cell lines has become the mainstream of research. Means, MDA-MB-231 cell conventional transfection method is the lentivirus method, although it can infect, but the efficiency is relatively low, only about 30%, and it needs to be screened by introducing additional resistance genes to increase the infection rate, but through drug The stable cells enriched by screening, the cell state is poor, and the positive rate of knockout in pool cells and monoclonal identification is relatively low, which restricts the gene editing efficiency of MDA-MB-231 cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Infection enhancing culture medium and method for improving cell lentivirus infection rate
  • Infection enhancing culture medium and method for improving cell lentivirus infection rate
  • Infection enhancing culture medium and method for improving cell lentivirus infection rate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-5

[0072] A method for improving the infection rate of MDA-MB-231 cells, comprising the following steps;

[0073] (1) Digest the MDA-MB-231 cells in the logarithmic growth phase into a suspension single-cell liquid, and prepare 1×10 5 Amount of cell inoculation per well Inoculate the single cell suspension into a 12-well cell culture plate, add 1ml of conventional medium, and culture at 37°C and ambient air, wherein the conventional medium contains glutamine and Leibovitz's L-15 medium with fetal bovine serum.

[0074] (2) When the MDA-MB-231 cells in step (1) are cultured for 36 hours, replace the conventional culture medium with enhanced infection medium, and cultivate them at 37°C and in an environment with a volume fraction of 5% carbon dioxide for 24 hours , wherein the components of the enhanced infection medium are shown in Table 1 below;

[0075] (3) Maintain the culture conditions of step (2), use the lentivirus with EGFP expression box to infect MDA-MB-231 cells, the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an infection enhancing culture medium and method for improving the cell lentivirus infection rate, and relates to the field of MDA-MB-231 cell transfection. The enhanced infection culture medium is used for improving the lentivirus infection rate of the MDA-MB-231 cell, and the enhanced infection culture medium is prepared from the following components: a Leibovitz's L-15 culture medium, an RPMI-1640 culture medium, fetal calf serum, non-essential amino acid and an epidermal growth factor; according to the volume percentage of the total raw materials, the addition amount of the fetal calf serum is 10%, and the addition amount of the non-essential amino acid is 1%; the addition amount of the epidermal growth factor is 2-3ng / ml. By adopting the enhanced infection culture medium disclosed by the invention, the MDA-MB-231 cells can be normally cultured in the conventional environment of 37 DEG C and 5% CO2, and the infection efficiency of the lentivirus on the MDA-MB-231 cells is more remarkably improved, so that the gene editing efficiency of the MDA-MB-231 cells becomes higher, and the problem that the lentivirus infection rate of the MDA-MB-231 cells is low at present is solved.

Description

technical field [0001] The invention relates to the field of MDA-MB-231 cell transfection, in particular to an enhanced infection medium and method for increasing the infection rate of cell lentivirus. Background technique [0002] MDA-MB-231 (human breast cancer cells) are human breast cancer cells isolated from the pleural effusion of a 51-year-old female breast cancer patient, MDA-MB-231 is a highly invasive and poorly differentiated triple-negative breast cancer (TNBC) cell line, triple negative refers to lack of estrogen receptor (ER) and progesterone receptor (PR) expression, and HER2 (human epidermal growth factor receptor 2) overexpression, similar to other invasive cancer cell lines, The invasiveness of MDA-MB-231 cells is mediated by proteolytic degradation of the extracellular matrix. [0003] MDA-MB-231 is widely used in research on triple-negative breast cancer. Gene editing through ZFN, TALEN, and CRISPR / Cas9 technologies to establish gene knockout, knockin, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/09C12N5/071C12N15/867C12N15/65
CPCC12N5/0631C12N5/0693C12N15/86C12N15/65C12N2500/32C12N2501/11C12N2501/30C12N2501/105C12N2740/15043C12N2510/00
Inventor 黄秋凤莫晓花沈于钰
Owner 广州源井生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products